Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 2): Clinical and Therapeutic Considerations.

Journal of cardiovascular translational research - 1 Jun 2017

Chirinos Julio A

Abstract excerpt

Multiple phase III trials over the last few decades have failed to demonstrate a clear benefit of various pharmacologic interventions in heart failure with a preserved left ventricular (LV) ejection fraction (HFpEF). Therefore, a better understanding of its pathophysiology is important. An accompanying review describes key technical and physiologic aspects regarding the deep phenotyping of arterial hemodynamics...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arteries
Share to Heart Failure
Share to Hemodynamics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Models, Cardiovascular

Share to Phenotype

Share to Predictive Value of Tests

Share to Prognosis

Share to Stroke Volume

Source

Open in PubMed Open full text

Identifiers

PMID: 28401511
DOI: 10.1007/s12265-017-9736-2
PMCID: PMC5515667

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 2): Clinical and Therapeutic Considerations.PMID 28401511Read ↗

Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 1): Physiologic and Technical Considerations.Semantic proximity Read ↗

Key Phenotypes of Heart Failure with Preserved Ejection Fraction: Pathophysiologic Mechanisms and Potential Treatment Strategies.Semantic proximity Read ↗

Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.Semantic proximity Read ↗

Primary heart failure with preserved ejection fraction: The intertwined pathophysiology and treatment of some of the most relevant phenotypes.Semantic proximity Read ↗

Hemodynamic Profile of Patients With Heart Failure and Preserved Ejection Fraction Vary by Age.Semantic proximity Read ↗

Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.Semantic proximity Read ↗

Heart failure with non-reduced ejection fraction: Epidemiology, pathophysiology, phenotypes, diagnosis and treatment approaches.Semantic proximity Read ↗

Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment.Semantic proximity Read ↗

Towards a phenotype profiling of the patients with heart failure and preserved ejection fractionSemantic proximity Read ↗

Exercise Induced Pulmonary Hypertension: What is New?Semantic proximity Read ↗

Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy.Semantic proximity Read ↗

Biological Phenotypes of Heart Failure With Preserved Ejection Fraction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.